Praxsyn Corporation

PXYN

US74006F1057

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 03:30:25 2024-03-22 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2020	Praxsyn Corporation Announces Appointment of Daniel Oswald as Chief Financial Officer	CI
2018	Praxsyn Corporation Announces Executive Changes	CI

Praxsyn Corporation Announces Resignation of Jonathan Renkas as Director

September 28, 2018 at 11:29 am EDT

On September 26, 2018, Dr. Jonathan Renkas submitted his resignation as a director of Praxsyn Corporation, effective September 28, 2018. Dr. Renkas’ resignation was not due to any disagreement or matter relating to the Company’s operations, policies or practices.

Latest news about Praxsyn Corporation

Praxsyn Corporation Announces Appointment of Daniel Oswald as Chief Financial Officer	20-01-22	CI
Praxsyn Corporation Announces Executive Changes	18-12-18	CI
Praxsyn Corporation Announces Resignation of Jonathan Renkas as Director	18-09-28	CI
Praxsyn Corporation Announces Management Appointment	18-09-20	CI
Praxsyn Corporation Announces Management Changes	18-09-06	CI
Praxsyn Corporation Announces Resignation of Kimberly A. Brooks as General Counsel and Secretary	18-07-10	CI
Praxsyn Corporation Announces the Resignation of Evon Midei as a Member of the Board of Director	17-12-21	CI
Praxsyn Corporation Announces Executive Changes	17-06-28	CI
Praxsyn Corporation Promotes Stephanie Kaitz to the Position of Financial Controller	17-04-27	CI
Praxsyn Corporation Announces Movement of Headquarters from Irvine, California to Las Vegas, Nevada	17-02-15	CI
Praxsyn Corporation Announces the Resignation of James Bradford from Board of Directors	16-06-19	CI
Praxsyn Corporation Mulls Acquisitions	16-04-15	CI
Praxsyn Corporation Announces Executive Changes	16-04-04	CI
Praxsyn Corporation Announces Resignation of Kelly Reynolds as Member of Board of Directors	16-03-27	CI
Praxsyn Corporation Appoints James Bradford as Member of the Board of Directors	15-12-15	CI
Praxsyn Corporation Board Appoints Justin Cary to Act as the Company's Chief Financial Officer	15-07-27	CI
Praxsyn Corporation Growth Requires Expansion into New Space	15-07-16	CI
Praxsyn Corporation Auditor Raises 'Going Concern' Doubt	15-04-14	CI
John Garbino Resigns as Member of the Board of Directors of Praxsyn Corporation, Effective February 23, 2015	15-02-25	CI
Praxsyn Corporation Finalizes Corporate Office Expansion in Irvine	15-01-13	CI
Praxsyn Corporation Announces Resignation of Directors	14-11-04	CI
PAWS Pet Company, Inc. has Changed its Name to Praxsyn Corporation	14-09-05	CI
Praxsyn Corporation Announces Management Changes	14-05-30	CI
Praxsyn Corporation Reports Sales Results for the Month of April 2014	14-05-05	CI
The PAWS Pet Company, Inc Elects John Garbino and Edward Kurtz as Members of the Board of Directors	14-04-04	CI

Chart Praxsyn Corporation

Duration

Period

More charts

Company Profile

Praxsyn Corporation is a holding company. The Company operates through its subsidiaries, Mesa Pharmacy, Inc. (Mesa) and Nevada Health RX, Inc (NHRX). Through Mesa, the Company focuses on administration and collection of its portfolio of Workers Compensation (WC) accounts receivable. Through NHRX, the Company markets medical supplies through direct sales to medical practitioners. Through Praxsyn Capital Corporation (PraxCapita), the Company provides revenue cycle management solutions for healthcare providers focusing on Personal Injury (PI) and WC. Through Praxsyn Medical Inc., the Company is engaged in retail pharmacy and medical supplies and equipment.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PRAXSYN CORPORATION	-.--%	847
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals